Abstract
Background
For prevention of sudden cardiac death, the transvenously implantable cardioverter-defibrillator therapy (tv-ICD) is well accepted. The subcutaneous system (S-ICD®) is promising in terms of reducing ICD complications. Nevertheless, the impact of the novel generator position on patients’ quality of life (QoL) is yet unknown.
Objective
This study aimed at comparing QoL and posttraumatic stress with both systems.
Methods
60 S-ICD® and 60 case–controlled tv single-chamber ICD patients were asked to respond to three standardized questionnaires. PDS [screening for posttraumatic stress disorders (PTSD)] and PHQ-D (detection of the most predominant psychological disorders) were used to screen for potential mental comorbidities. The SF-12 questionnaire was used to evaluate physical and mental well-being. Groups were compared in terms of QoL and PTSD.
Results
n = 42 (70%) pairs were analyzed (n = 30 male, mean age 44.6 ± 12.2 years). Prior appropriate (p = 0.06) or inappropriate episodes (p = 0.24), ejection fraction (p = 0.28), or underlying cardiac disease did not differ significantly between groups. PDS revealed a PTSD in n = 6 tv-ICD and n = 6 S-ICD® patients (14.3%) equally. In the PHQ-D questionnaire, n = 4 tv-ICD and n = 2 S-ICD® patients fulfilled criteria for a major depression (p = 0.68). Panic disorders (n = 2 tv, n = 0 S-ICD®, p = 0.5), and anxiety disorders (n = 3 S-ICD®, n = 0 tv-ICD, p = 0.24) did not differ between groups. The physical well-being score was 39.9 ± 12.5 in patients with a tv-ICD compared to 46.6 ± 9.9 in S-ICD® patients (p = 0.01). The mental well-being score was comparable in both groups (tv-ICD 51.8 ± 10.8 vs. S-ICD® 51.9 ± 10.4, p = 0.95).
Conclusions
Our case–control study revealed equal or even better physical well-being of patients with the S-ICD®. PTSD occurred in almost 15% of ICD patients irrespective of the type of system.
Similar content being viewed by others
References
Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekval TM, Spaulding C, Van Veldhuisen DJ (2015) 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 17(11):1601–1687
Irvine J, Dorian P, Baker B, O’Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ (2002) Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J 144:282–289
Bedair R, Babu-Narayan SV, Dimopoulos K, Quyam S, Doyle AM, Swan L, Gatzoulis MA, Wong T (2015) Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease. Int J Cardiol 181:218–224
Sears SF Jr, Todaro JF, Lewis TS, Sotile W, Conti JB (1999) Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol 22:481–489
Bunz M, Lenski D, Wedegartner S, Ukena C, Karbach J, Bohm M, Kindermann I (2016) Heart-focused anxiety in patients with chronic heart failure before implantation of an implantable cardioverter defibrillator: baseline findings of the anxiety-CHF study. Clin Res Cardiol 105:216–224
Pedersen SS, van den Broek KC, Sears SF Jr (2007) Psychological intervention following implantation of an implantable defibrillator: a review and future recommendations. Pacing Clin Electrophysiol 30:1546–1554
Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L, Theuns D, Park RE, Wright DJ, Connelly DT, Fynn SP, Murgatroyd FD, Sperzel J, Neuzner J, Spitzer SG, Ardashev AV, Oduro A, Boersma L, Maass AH, Van Gelder IC, Wilde AA, van Dessel PF, Knops RE, Barr CS, Lupo P, Cappato R, Grace AA (2010) An entirely subcutaneous implantable cardioverter-defibrillator. N Engl J Med 363:36–44
Bettin M, Reinke F, Rath B, Kobe J, Eckardt L (2015) Recent advances in the entirely subcutaneous ICD system. F1000prime Rep 7:46
Burke MC, Gold MR, Knight BP, Barr CS, Theuns DA, Boersma LV, Knops RE, Weiss R, Leon AR, Herre JM, Husby M, Stein KM, Lambiase PD (2015) Safety and Efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS Registry. J Am Coll Cardiol 65:1605–1615
Frommeyer G, Dechering DG, Zumhagen S, Loher A, Kobe J, Eckardt L, Reinke F (2016) Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experience. Clin Res Cardiol 105:89–93
Spitzer RL, Kroenke K, Williams JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient Health Questionnaire. JAMA 282:1737–1744
McCarthy S (2008) Post-traumatic Stress Diagnostic Scale (PDS). Occup Med (Lond) 58:379
Ware J Jr, Kosinski M, Keller SD (1996) A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 34:220–233
De Smedt D, Clays E, Doyle F, Kotseva K, Prugger C, Pajak A, Jennings C, Wood D, De Bacquer D (2013) Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients. Int J Cardiol 167:2294–2299
Jarman JW, Lascelles K, Wong T, Markides V, Clague JR, Till J (2012) Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 33:1351–1359
Bordachar P, Marquie C, Pospiech T, Pasquie JL, Jalal Z, Haissaguerre M, Thambo JB (2015) Subcutaneous implantable cardioverter defibrillators in children, young adults and patients with congenital heart disease. Int J Cardiol 203:251–258
Dunbar SB, Dougherty CM, Sears SF, Carroll DL, Goldstein NE, Mark DB, McDaniel G, Pressler SJ, Schron E, Wang P, Zeigler VL (2012) Educational and psychological interventions to improve outcomes for recipients of implantable cardioverter defibrillators and their families: a scientific statement from the American Heart Association. Circulation 126:2146–2172
Heidbuchel H, Carre F (2014) Exercise and competitive sports in patients with an implantable cardioverter-defibrillator. Eur Heart J 35:3097–3102
Verkerk AJ, Vermeer AM, Smets EM, Dekker LR, Wilde AA, Van Langen IM, Christiaans I, Nieuwkerk PT (2015) Quality of life in young adult patients with a cardiogenetic condition receiving an ICD for primary prevention of sudden cardiac death. Pacing Clin Electrophysiol 38:870–877
Sears SF, Hauf JD, Kirian K, Hazelton G, Conti JB (2011) Posttraumatic stress and the implantable cardioverter-defibrillator patient: what the electrophysiologist needs to know. Circ Arrhythm Electrophysiol 4:242–250
Pedersen SS, den Broek KC, Theuns DA, Erdman RA, Alings M, Meijer A, Jordaens L, Denollet J (2011) Risk of chronic anxiety in implantable defibrillator patients: a multi-center study. Int J Cardiol 147:420–423
Lambiase PD, Barr C, Theuns DA, Knops R, Neuzil P, Johansen JB, Hood M, Pedersen S, Kaab S, Murgatroyd F, Reeve HL, Carter N, Boersma L (2014) Worldwide experience with a totally subcutaneous implantable defibrillator: early results from the EFFORTLESS S-ICD Registry. Eur Heart J 35:1657–1665
Dougherty CMFA, Eaton LH, Morrison ML, Kim MS, Thompson EA (2016) Comparison of patient and partner quality of life and health outcomes in the first year after an implantable cardioverter defibrillator (ICD). J Behav Med 39:94–106
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
J.K., M.B., G.F, F.R., D.D and L.E.: travel grants and lecture honoraria from BIOTRONIK, Boston Scientific, Medtronic, Sorin Group and St. Jude Medical. K.H., N.G, M.B.: none related to the study.
Additional information
J. Köbe and K. Hucklenbroich contributed equally to this work.
Rights and permissions
About this article
Cite this article
Köbe, J., Hucklenbroich, K., Geisendörfer, N. et al. Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems. Clin Res Cardiol 106, 317–321 (2017). https://doi.org/10.1007/s00392-016-1055-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-016-1055-0